9amHealth Review
Best for: Insured patients wanting branded GLP-1s within a full cardiometabolic care program
9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus FDA-approved generics. Membership is $149/month or free when covered by insurance, and includes specialist visits, labs, lifestyle support, and medications. The care team includes physicians, board-certified obesity specialists (DABOM), endocrinologists, dietitians, and pharmacists. The team helps navigate insurance through employer and state-plan partnerships.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
9amHealth is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
9amHealth prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Membership (self-pay; free w/ insurance) | brand | $149 |
✓ Pros
- •Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- •$149/month membership or free when covered by insurance
- •Membership includes specialists, labs, devices, and medications
- •Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- •Helps navigate insurance approvals; employer and state-plan partnerships
- •Home lab draws available in some areas
- •Cardiometabolic whole-body care beyond weight loss
✗ Cons
- •Medication coverage and GLP-1 access depend on insurance and BMI criteria
- •State availability not enumerated on the public site
- •Branded GLP-1s can be costly without insurance coverage
- •Pricing for medications not transparently listed
Ready to start with 9amHealth?
Starting at $149/month. See current pricing and start your free consultation.
Sources & methodology
Our 9amHealth review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to 9amHealth
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with 9amHealth?
Starting at $149/month. See current pricing and start your free consultation.